NexgenRx Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
For the six months, revenue was CAD 6.88 million compared to CAD 6.29 million a year ago. Net income was CAD 0.18634 million compared to CAD 0.408024 million a year ago. Basic earnings per share from continuing operations was CAD 0.003 compared to CAD 0.006 a year ago. Diluted earnings per share from continuing operations was CAD 0.002 compared to CAD 0.005 a year ago.